Stock Market Recap: Healthcare and Pharma Lead Gainers, Banking and Oil & Gas Stocks Decline
In yesterday’s stock market activity, the healthcare and pharma sectors emerged as the top gainers, while banking and oil & gas stocks faced a decline. Let’s take a closer look at the key highlights from the market and other notable developments.
Table of Contents
Top Gainers:
Healthcare and pharma stocks dominated the market gains, with notable performers including:
- NIFTY 50
- SBI Life: Rs 1,413.95, up by 3.97%
- HDFC Life: Rs 651.80, up by 2.65%
- Apollo Hospitals: Rs 5,478.95, up by 2.63%
- L&T: Rs 3,109.00, up by 1.90%
- Hero Moto: Rs 3,334.75, up by 1.67%
Top Losers:
Conversely, the top losers in the market were:
- NIFTY 50
- SBI: Rs 563.05, down by 3.69%
- Axis Bank: Rs 994.35, down by 3.12%
- ONGC: Rs 196.35, down by 2.70%
- BPCL: Rs 390.25, down by 2.11%
- Bajaj Finance: Rs 7,221.00, down by 1.92%
Market Overview:
In other Asian markets, all except Hong Kong closed positively, indicating a mixed regional sentiment.
Telecom Sector Insights:
- Jio added 32.4 lakh users in August.
- Airtel gained 12.17 lakh wireless subscribers.
- Vodafone-Idea (Vi) lost 49,782 users.
Patent Milestone:
The Indian patent office has achieved a record high, granting 41,010 patents in the current financial year until November, as announced by Union Minister Piyush Goyal.
Infrastructure and Economic Indicators:
- The speed of national highway construction in India averaged 20.78 km-per-day during the first 7 months of the current financial year, according to the Ministry of Road Transport and Highways.
- Domestic air passenger traffic increased by 11% year-on-year to 1.26 crore passengers in October.
Tech and Market Trends:
- India’s PC market, including desktops, notebooks, and workstations, experienced a 14% year-on-year increase, recording 45 lakh units in shipments in the July-Sept quarter 2023, according to the International Data Corporation.
Financial News:
- The Reserve Bank of India (RBI) is set to conduct a 14-day variable rate reverse repo (VRRR) auction for Rs 50,000 crore on 17 Nov.
- The National Payments Corporation of India (NPCI) has directed payment apps and banks to deactivate UPI IDs and numbers inactive for over a year.
Stocks in the Spotlight:
- SBI plans to launch its banking mobile app Yono Global in Singapore and the US.
- JSW Infra wins the bid for the development of a greenfield port at Keni in Karnataka on a Public Private Partnership basis.
- AGS Transact secures a Rs 1,100 crore order for deploying 2,500+ ATMs for SBI over the next 7 years.
- GMR Infra’s Goa International Airport raises Rs 2,475 crore through 20-year non-convertible debenture (NCD) bonds.
- IndiGo has achieved a significant milestone by becoming the first Indian airline to schedule and operate more than 2000 flights in a single day.
- Airtel rolls out its 5G Plus services in all 38 districts of Tamil Nadu.
- TVS Motor signs an import and distribution agreement with Emil Frey for the European market.
IPO Corner:
Upcoming IPO – Flair Writing Industries IPO:
- Open dates: 22-24 Nov
- Price band: Rs 288 to Rs 304 per share
One Day Changes:
- Gold: Rs 60,935, up by 1.23%
- Silver: Rs 73,810, up by 1.45%
- USD-INR: Rs 83.27/USD, up by 0.04%
- Dow Jones: 34,945.47, down by 0.13%
- Nasdaq: 14,113.67, up by 0.07%
Long-Term Returns (Past 20 Years):
- Sensex: 13.82% p.a. (Annualized)
- Nifty: 13.46% p.a. (Annualized)
- Dow Jones: 6.61% p.a. (Annualized)
- Nasdaq: 10.52% p.a. (Annualized)
The stock market exhibited a mixed performance, with healthcare and pharma leading the gainers and banking and oil & gas facing declines. Various economic indicators, technological advancements, and corporate developments continue to shape the market landscape. Investors are advised to stay informed and make decisions based on a thorough understanding of market trends and company-specific updates.
Can you be more specific about the content of your article? After reading it, I still have some doubts. Hope you can help me.
I don’t think the title of your article matches the content lol. Just kidding, mainly because I had some doubts after reading the article.
Your point of view caught my eye and was very interesting. Thanks. I have a question for you.